Novartis Bioventures Ltd, 10% Owner at Aerpio Pharmaceuticals, Inc. (ARPO), sold 188,627 shares at $0.96 ($185K) on 2019-04-03, disclosed to the SEC on 2019-04-05.
Open-market sale of $185k ARPO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 58,033 | $56K | 30.1% |
| 2 | $0.96 | 58,033 | $56K | 30.1% |
| 3 | $1.01 | 47,900 | $48K | 26.2% |
| 4 | $1.02 | 24,661 | $25K | 13.6% |
| Total | $0.98 avg | 188,627 | $185K | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |